Pliant Therapeutics (PLRX) Current Leases (2021 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Current Leases of $1.7 million for Q1 2026, up 122.18% year-over-year from $771000.0 in Q1 2025, and up 18.38% quarter-over-quarter from $1.4 million in Q4 2025.
Pliant Therapeutics (PLRX) Current Leases (2021 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Current Leases for 6 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 122.18% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 122.18% YoY), while the FY2025 annual figure was $1.4 million, up 166.97% from the prior year.
- Current Leases grew to $1.7 million in Q1 2026 per PLRX's latest filing, from $1.4 million in the prior quarter.
- Across five years, Current Leases topped out at $2.6 million in Q3 2022 and bottomed at $98000.0 in Q2 2024.
- Historically, Current Leases has averaged $1.5 million across 5 years, with a median of $1.4 million in 2025.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 95.61% — and 2025, when it surged 1150.0%.
- Pliant Therapeutics' Current Leases stood at $2.5 million in 2022, then plunged by 46.36% to $1.3 million in 2023, then plunged by 58.88% to $542000.0 in 2024, then surged by 166.97% to $1.4 million in 2025, then rose by 18.38% to $1.7 million in 2026.
- Business Quant data shows PLRX's Current Leases at $1.7 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | 2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 771,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 2.46 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 1.87 Mn |